Xbrane Biopharma AB (7XB.F) Q2 2024 Earnings

16MayConfirmed
Q2 2024
-0.01
-0.01
-0.01
-0

Details

Expected EPS
-0.0038685644880000003
Actual EPS
-0.007780871044840001
Surprise EPS
-0
Surprise Percent
+101.13%

Description

Xbrane Biopharma AB (7XB.F) has reported earnings of -0.007780871044840001 per share for Q2 2024.

0 Comments

Share your thoughts